Alvaro Fabio Madrid Espinoza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alvaro Fabio Madrid Espinoza has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Edwin Alonso Varillas Reyes1 shared publication
Edwin Varillas
School of Medicine, Universidad Peruana Cayetano Heredia, 430 Honorio Delgado Avenue, Lima, 15102, Peru
1 shared publicationFiorella Krapp
School of Medicine, Universidad Peruana Cayetano Heredia, 430 Honorio Delgado Avenue, Lima, 15102, Peru
1 shared publication- Fiorella Krapp
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia
1 shared publication Gustavo Gutierrez Batallanos
School of Medicine, Universidad Peruana Cayetano Heredia, 430 Honorio Delgado Avenue, Lima, 15102, Peru
1 shared publication- Gustavo Gutierrez Batallanos1 shared publication
Latest Publications
- Open Access
- 4 August 2026
- Published by Elsevier in New Microbes and New Infections
- Vol. 73, 101824
High prevalence of intestinal colonization by beta-lactam resistant Enterobacterales in patients admitted to an emergency department in Lima, Peru
- 4 August 2026
- Published by Elsevier in New Microbes and New Infections
- Vol. 73, 101824
Open AccessHigh prevalence of intestinal colonization by beta-lactam resistant Enterobacterales in patients admitted to an emergency department in Lima, Peru
- Open Access
- 25 March 2026
- Published by Elsevier in SSRN Electronic Journal
High prevalence of intestinal colonization by beta-lactam resistant Enterobacterales in patients admitted to an emergency department in Lima, Peru
Objectives: To determine the prevalence of intestinal colonization by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) and carbapenem resistant Enterobacterales (CRE) among patients admitted to the emergency department of a tertiary care hospital in Lima, Peru. Factors associated with colonization were also evaluated.Methods: A cross-sectional study was conducted from December 2019 to March 2020. Patients were enrolled on one to two randomly selected days per week. A rectal or fecal swab was collected, and a standardized questionnaire was administered. Samples were cultured in chromogenic media (ChromAgar ESBL and ChromAgar mSuperCarba) and disc diffusion methods were used for confirmation of ESBL production and carbapenem resistance . The association of epidemiological and clinical factors with ESBL-E and CRE colonization was analyzed using bivariate generalized linear models with a Poisson distribution and robust variance.Results: 148 patients were sampled. Prevalence of ESBL-E and CRE colonization was 73.6% (109/148) and 8.1% (12/148), respectively. Hospitalization during the previous year (PR = 1.23, 95% CI: 1.02–1.49) was associated with ESBL-E colonization.Conclusions: A high prevalence of ESBL-E intestinal colonization and ongoing undetected CRE colonization were found among patients with and without prior healthcare exposure admitted to an emergency department of a tertiary care hospital in Lima.
- 25 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessHigh prevalence of intestinal colonization by beta-lactam resistant Enterobacterales in patients admitted to an emergency department in Lima, Peru
Objectives: To determine the prevalence of intestinal colonization by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) and carbapenem resistant Enterobacterales (CRE) among patients admitted to the emergency department of a tertiary care hospital in Lima, Peru. Factors associated with colonization were also evaluated.Methods: A cross-sectional study was conducted from December 2019 to March 2020. Patients were enrolled on one to two randomly selected days per week. A rectal or fecal swab was collected, and a standardized questionnaire was administered. Samples were cultured in chromogenic media (ChromAgar ESBL and ChromAgar mSuperCarba) and disc diffusion methods were used for confirmation of ESBL production and carbapenem resistance . The association of epidemiological and clinical factors with ESBL-E and CRE colonization was analyzed using bivariate generalized linear models with a Poisson distribution and robust variance.Results: 148 patients were sampled. Prevalence of ESBL-E and CRE colonization was 73.6% (109/148) and 8.1% (12/148), respectively. Hospitalization during the previous year (PR = 1.23, 95% CI: 1.02–1.49) was associated with ESBL-E colonization.Conclusions: A high prevalence of ESBL-E intestinal colonization and ongoing undetected CRE colonization were found among patients with and without prior healthcare exposure admitted to an emergency department of a tertiary care hospital in Lima.